BPC-157: The Bodys Own Repair Peptide BPC-157 or Body Protection Compound 157 is a synthetic peptide engineered from a protein that is found naturally in gastric juice
Studies have shown that Semaglutide significantly reduces albuminuria, indicating improved kidney function and decreased inflammation
"Semaglutide has been studied in large real-world evidence studies and robust clinical development programmes." The drug is also being examined in a trial called Focus, which concludes in 2027, to assess its long-term effects on diabetic retinopathy - an eye condition in type 2 diabetes patients
Muller, P
but exogenous estrogen replacement in post-menopausal women was found to have several adverse side effects, therefore this treatment is not recommended (Rajfer et al
Cockhill J, Jhamandas K, Boegman RJ, Beninger RJ (1992) Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage